Log in

NASDAQ:HCATHealth Catalyst Stock Price, Forecast & News

$30.00
+1.45 (+5.08 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.60
Now: $30.00
$30.87
50-Day Range
$26.81
MA: $28.86
$32.87
52-Week Range
$17.48
Now: $30.00
$49.85
Volume711,432 shs
Average Volume773,219 shs
Market Capitalization$1.14 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States. The company operates through two segments, Technology and Professional services. Its products include cloud-based data platform, analytics software, and professional services. The company offers Data Operating System (DOS), a data platform that allows customers to integrate and organize their disparate data sources to enable analytics, including healthcare-specific terminology, data governance, and meta-data management. It also develops foundational software applications comprising Population Builder application that enables clinicians and administrators to author, manage, view, and publish pre-built and custom population ruleset definitions; Touchstone application for benchmarking solutions; and Leading Wisely application for dashboards and reporting solutions. In addition, the company provides domain-specific software applications, such as CORUS application for activity-based costing; patient safety monitor analytics; care management services; population health foundations solutions; and quality and regulatory measures solutions. Further, it offers analytics accelerators, which facilitate analytic insights across clinical, financial, and operational use-cases. Additionally, the company provides data and analytics services, including data engineering, analytic engineer, implementation, data science, analytics strategy, and data governance services; and clinical, financial, and operational services comprising quality and process improvement strategy, patient safety, cost accounting, population health and value-based care, abstraction data submission, and health catalyst university educational services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.79 out of 5 stars


Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HCAT
CUSIPN/A
CIKN/A
Phone801-708-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$154.94 million
Book Value$5.49 per share

Profitability

Net Income$-60,100,000.00

Miscellaneous

Employees900
Market Cap$1.14 billion
Next Earnings Date8/27/2020 (Estimated)
OptionableNot Optionable

Receive HCAT News and Ratings via Email

Sign-up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

Health Catalyst (NASDAQ:HCAT) Frequently Asked Questions

How has Health Catalyst's stock been impacted by COVID-19 (Coronavirus)?

Health Catalyst's stock was trading at $27.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HCAT shares have increased by 8.8% and is now trading at $30.00. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Health Catalyst?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Health Catalyst.

When is Health Catalyst's next earnings date?

Health Catalyst is scheduled to release its next quarterly earnings announcement on Thursday, August 27th 2020. View our earnings forecast for Health Catalyst.

How were Health Catalyst's earnings last quarter?

Health Catalyst (NASDAQ:HCAT) released its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.25) by $0.09. The company earned $45.12 million during the quarter, compared to the consensus estimate of $44.12 million. Health Catalyst had a positive return on equity of 30.42% and a negative net margin of 38.74%. The firm's quarterly revenue was up 28.1% compared to the same quarter last year. View Health Catalyst's earnings history.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its second quarter 2020 After-Hours earnings guidance on Tuesday, May, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $40.8-43.8 million, compared to the consensus revenue estimate of $43.3 million.

What price target have analysts set for HCAT?

13 equities research analysts have issued 1-year target prices for Health Catalyst's stock. Their forecasts range from $32.00 to $50.00. On average, they anticipate Health Catalyst's share price to reach $40.92 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price. View analysts' price targets for Health Catalyst.

Has Health Catalyst been receiving favorable news coverage?

Media coverage about HCAT stock has been trending negative recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Health Catalyst earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days. View the latest news about Health Catalyst.

Are investors shorting Health Catalyst?

Health Catalyst saw a increase in short interest in June. As of June 15th, there was short interest totaling 6,020,000 shares, an increase of 5.8% from the May 31st total of 5,690,000 shares. Based on an average trading volume of 812,600 shares, the short-interest ratio is currently 7.4 days. Approximately 25.5% of the company's shares are short sold. View Health Catalyst's Current Options Chain.

Who are some of Health Catalyst's key competitors?

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), salesforce.com (CRM), Walt Disney (DIS), Alibaba Group (BABA), Alteryx (AYX), Bank of America (BAC), Mastercard (MA), ServiceNow (NOW), Paypal (PYPL) and Square (SQ).

Who are Health Catalyst's key executives?

Health Catalyst's management team includes the following people:
  • Mr. Daniel D. Burton, CEO & Director (Age 45, Pay $497.11k)
  • Mr. Paul Horstmeier, Chief Operating Officer (Age 59, Pay $433.53k)
  • Mr. Dale Sanders, Chief Technology Officer (Age 60, Pay $510.82k)
  • Mr. Steven C. Barlow, Co-Founder & Sr. VP (Leave of Absence)
  • Mr. Thomas D. Burton, Co-Founder & Pres of Professional Services

When did Health Catalyst IPO?

(HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

What is Health Catalyst's stock symbol?

Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."

How do I buy shares of Health Catalyst?

Shares of HCAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Health Catalyst's stock price today?

One share of HCAT stock can currently be purchased for approximately $30.00.

How big of a company is Health Catalyst?

Health Catalyst has a market capitalization of $1.14 billion and generates $154.94 million in revenue each year. The company earns $-60,100,000.00 in net income (profit) each year or ($1.42) on an earnings per share basis. Health Catalyst employs 900 workers across the globe.

What is Health Catalyst's official website?

The official website for Health Catalyst is www.healthcatalyst.com.

How can I contact Health Catalyst?

Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The company can be reached via phone at 801-708-6800 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.